{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:18:48Z","timestamp":1792664328466,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.chest.2019.04.101","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T02:41:56Z","timestamp":1557456116000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"title":["Group 2 Innate Lymphoid Cells in Airway Diseases"],"prefix":"10.1016","volume":"156","author":[{"given":"Atsushi","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.chest.2019.04.101_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.chest.2019.04.101_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coi.2018.11.003","article-title":"Cellular pathways in the development of human and murine innate lymphoid cells","volume":"56","author":"Scoville","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12708","article-title":"New insights into the function, development, and plasticity of type 2 innate lymphoid cells","volume":"286","author":"Krabbendam","year":"2018","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.chest.2019.04.101_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","article-title":"IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in\u00a0vivo","volume":"15","author":"Fort","year":"2001","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.chest.2019.04.101_bib5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/intimm\/dxn037","article-title":"Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system","volume":"20","author":"Kondo","year":"2008","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.chest.2019.04.101_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells: a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.chest.2019.04.101_bib7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mjosberg","year":"2011","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/imr.12706","article-title":"The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms","volume":"286","author":"Kabata","year":"2018","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/imr.12557","article-title":"Innate and adaptive type 2 immunity in lung allergic inflammation","volume":"278","author":"Kubo","year":"2017","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.alit.2018.11.001","article-title":"Airway innate lymphoid cells in the induction and regulation of allergy","volume":"68","author":"Doherty","year":"2019","journal-title":"Allergol Int"},{"issue":"7585","key":"10.1016\/j.chest.2019.04.101_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature16161","article-title":"Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit","volume":"529","author":"von Moltke","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.chest.2019.04.101_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaci.2018.03.019","article-title":"Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps","volume":"142","author":"Kohanski","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"28","key":"10.1016\/j.chest.2019.04.101_bib13","doi-asserted-by":"crossref","first-page":"eaat9453","DOI":"10.1126\/sciimmunol.aat9453","article-title":"The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation","volume":"3","author":"Bankova","year":"2018","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.chest.2019.04.101_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.imlet.2007.07.002","article-title":"Intracellular JNK, p38 MAPK and NF-\u03baB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes","volume":"112","author":"Wong","year":"2007","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/imr.12558","article-title":"IL-25 in allergic inflammation","volume":"278","author":"Xu","year":"2017","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1016\/j.chest.2019.04.101_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.chest.2019.04.101_bib17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ni.3447","article-title":"IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity","volume":"17","author":"Ohne","year":"2016","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.chest.2019.04.101_bib18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ni.3444","article-title":"IL-1\u03b2, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs","volume":"17","author":"Bal","year":"2016","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.chest.2019.04.101_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41590-018-0201-4","article-title":"Tissue signals imprint ILC2 identity with anticipatory function","volume":"19","author":"Ricardo-Gonzalez","year":"2018","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.immuni.2016.11.005","article-title":"Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency","volume":"46","author":"Simoni","year":"2017","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.chest.2019.04.101_bib21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/mi.2013.114","article-title":"The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells","volume":"7","author":"Meylan","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"3","key":"10.1016\/j.chest.2019.04.101_bib22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/mi.2013.92","article-title":"TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers","volume":"7","author":"Yu","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"5","key":"10.1016\/j.chest.2019.04.101_bib23","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.jaci.2018.01.028","article-title":"GITR cosignal in ILC2s controls allergic lung inflammation","volume":"141","author":"Nagashima","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2 suppl","key":"10.1016\/j.chest.2019.04.101_bib24","doi-asserted-by":"crossref","first-page":"AB1","DOI":"10.1016\/j.jaci.2017.12.002","article-title":"Role of TNFSF11 and group 2 innate lymphoid cells in type 2 inflammation in chronic rhinosinusitis with nasal polyps","volume":"141","author":"Ogasawara","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7280","key":"10.1016\/j.chest.2019.04.101_bib25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.chest.2019.04.101_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","article-title":"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells","volume":"37","author":"Mjosberg","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.chest.2019.04.101_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","article-title":"Enhanced innate type 2 immune response in peripheral blood from patients with asthma","volume":"134","author":"Bartemes","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.chest.2019.04.101_bib28","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaci.2013.03.048","article-title":"Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production","volume":"132","author":"Doherty","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2016.11.023","article-title":"Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease","volume":"140","author":"Eastman","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.chest.2019.04.101_bib31","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/mi.2016.4","article-title":"IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection","volume":"9","author":"Pelly","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.20161274","article-title":"Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s","volume":"214","author":"von Moltke","year":"2017","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.chest.2019.04.101_bib33","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaci.2016.12.958","article-title":"Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines","volume":"140","author":"Salimi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.chest.2019.04.101_bib34","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.immuni.2015.02.007","article-title":"ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity","volume":"42","author":"Maazi","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.chest.2019.04.101_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/iid3.161","article-title":"Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps","volume":"5","author":"Poposki","year":"2017","journal-title":"Immun Inflamm Dis"},{"issue":"6","key":"10.1016\/j.chest.2019.04.101_bib36","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41385-018-0064-x","article-title":"C3a is required for ILC2 function in allergic airway inflammation","volume":"11","author":"Gour","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"7671","key":"10.1016\/j.chest.2019.04.101_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature23469","article-title":"Neuronal regulation of type 2 innate lymphoid cells via neuromedin U","volume":"549","author":"Cardoso","year":"2017","journal-title":"Nature"},{"issue":"7470","key":"10.1016\/j.chest.2019.04.101_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","article-title":"Type 2 innate lymphoid cells control eosinophil homeostasis","volume":"502","author":"Nussbaum","year":"2013","journal-title":"Nature"},{"issue":"6393","key":"10.1016\/j.chest.2019.04.101_bib39","doi-asserted-by":"crossref","first-page":"eaan8546","DOI":"10.1126\/science.aan8546","article-title":"Pulmonary neuroendocrine cells amplify allergic asthma responses","volume":"360","author":"Sui","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.chest.2019.04.101_bib40","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ni.3443","article-title":"Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs","volume":"17","author":"Silver","year":"2016","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.chest.2019.04.101_bib41","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.4049\/jimmunol.1601421","article-title":"Cutting edge: notch signaling promotes the plasticity of group-2 innate lymphoid cells","volume":"198","author":"Zhang","year":"2017","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaci.2018.03.007","article-title":"IL-17-producing ST2+ group 2 innate lymphoid cells play a pathogenic role in lung inflammation","volume":"143","author":"Cai","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.chest.2019.04.101_bib43","first-page":"108","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis","volume":"8","author":"Wise","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.chest.2019.04.101_bib44","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaci.2013.12.1086","article-title":"Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84","volume":"133","author":"Doherty","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.chest.2019.04.101_bib45","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/rccm.201609-1846OC","article-title":"Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens","volume":"195","author":"Dhariwal","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2019.04.101_bib46","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jaci.2014.07.029","article-title":"Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy","volume":"134","author":"Lao-Araya","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.chest.2019.04.101_bib47","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jaci.2018.06.041","article-title":"Role of IL-35 in sublingual allergen immunotherapy","volume":"143","author":"Shamji","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.chest.2019.04.101_bib48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11882-014-0435-7","article-title":"Cytokine profiles in allergic rhinitis","volume":"14","author":"Scadding","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"10.1016\/j.chest.2019.04.101_bib49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1398-9995.2009.02252.x","article-title":"Opposing roles of IL-17A and IL-25 in the regulation of TSLP production in human nasal epithelial cells","volume":"65","author":"Xu","year":"2010","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.chest.2019.04.101_bib50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00016480802225884","article-title":"Overexpression of thymic stromal lymphopoietin in allergic rhinitis","volume":"129","author":"Mou","year":"2009","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"10.1016\/j.chest.2019.04.101_bib51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaci.2016.06.063","article-title":"Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois","volume":"139","author":"Tan","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.chest.2019.04.101_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.alit.2014.12.006","article-title":"Immunopathology of chronic rhinosinusitis","volume":"64","author":"Kato","year":"2015","journal-title":"Allergol Int"},{"issue":"4","key":"10.1016\/j.chest.2019.04.101_bib53","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1164\/rccm.201212-2227OC","article-title":"IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps","volume":"188","author":"Shaw","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clim.2014.09.007","article-title":"Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness","volume":"155","author":"Walford","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.chest.2019.04.101_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2016.07.010","article-title":"Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis","volume":"170","author":"Tojima","year":"2016","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.chest.2019.04.101_bib56","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1111\/all.13552","article-title":"Epithelial activators of type 2 inflammation: elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois","volume":"73","author":"Ogasawara","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D2: a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.chest.2019.04.101_bib58","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.rmed.2015.09.016","article-title":"Type 2 innate lymphoid cells: a novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma","volume":"109","author":"Liu","year":"2015","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaci.2015.05.037","article-title":"Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia","volume":"137","author":"Smith","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.chest.2019.04.101_bib60","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/rccm.201612-2427OC","article-title":"Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in subjects with asthma","volume":"196","author":"Chen","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chest.2019.04.101_bib61","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ng.888","article-title":"Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations","volume":"43","author":"Torgerson","year":"2011","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.chest.2019.04.101_bib62","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaci.2009.04.018","article-title":"A\u00a0thymic stromal lymphopoietin gene variant is associated with asthma and airway hyperresponsiveness","volume":"124","author":"He","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"13","key":"10.1016\/j.chest.2019.04.101_bib63","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","article-title":"A\u00a0large-scale, consortium-based genome-wide association study of asthma","volume":"363","author":"Moffatt","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2019.04.101_bib64","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2009.12.935","article-title":"Increased IL-33 expression by epithelial cells in bronchial asthma","volume":"125","author":"Prefontaine","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaci.2011.08.031","article-title":"Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma","volume":"129","author":"Shikotra","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaci.2017.03.032","article-title":"Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin","volume":"141","author":"Liu","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.chest.2019.04.101_bib67","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.20070406","article-title":"IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells","volume":"204","author":"Wang","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"10.1016\/j.chest.2019.04.101_bib68","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.1800709","article-title":"Bronchial allergen challenge of patients with atopic asthma triggers an alarmin (IL-33, TSLP, and IL-25) response in the airways epithelium and submucosa","volume":"201","author":"Wang","year":"2018","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.chest.2019.04.101_bib69","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.chest.2017.05.019","article-title":"New anti-eosinophil drugs for asthma and COPD: targeting the trait!","volume":"152","author":"Bel","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.chest.2019.04.101_bib70","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3389\/fimmu.2018.02694","article-title":"Social networking of group two innate lymphoid cells in allergy and asthma","volume":"9","author":"Hurrell","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib71","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.immuni.2015.06.021","article-title":"An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T\u00a0cell numbers","volume":"43","author":"Morita","year":"2015","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.chest.2019.04.101_bib72","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jaci.2016.08.034","article-title":"Type 2 innate lymphoid cell suppression by regulatory T\u00a0cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction","volume":"139","author":"Rigas","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.chest.2019.04.101_bib73","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jaci.2017.09.025","article-title":"IL-10, TGF-\u03b2, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells","volume":"141","author":"Ogasawara","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ni.3308","article-title":"Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells","volume":"17","author":"Duerr","year":"2016","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib75","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ni.3309","article-title":"Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses","volume":"17","author":"Moro","year":"2016","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.chest.2019.04.101_bib76","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jaci.2017.04.043","article-title":"Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell-mediated airway hyperreactivity","volume":"141","author":"Maazi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.chest.2019.04.101_bib77","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jaci.2017.09.050","article-title":"Prostaglandin E2 suppresses human group 2 innate lymphoid cell function","volume":"141","author":"Maric","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2019.04.101_bib78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1164\/rccm.201410-1793OC","article-title":"Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses","volume":"193","author":"Zhou","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"6379","key":"10.1016\/j.chest.2019.04.101_bib79","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.aan4829","article-title":"\u03b22-Adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses","volume":"359","author":"Moriyama","year":"2018","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.chest.2019.04.101_bib80","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.celrep.2017.10.110","article-title":"Testosterone attenuates group 2 innate lymphoid cell-mediated airway inflammation","volume":"21","author":"Cephus","year":"2017","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.chest.2019.04.101_bib81","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1084\/jem.20161807","article-title":"Androgen signaling negatively controls group 2 innate lymphoid cells","volume":"214","author":"Laffont","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.chest.2019.04.101_bib82","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/ncomms3675","article-title":"Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation","volume":"4","author":"Kabata","year":"2013","journal-title":"Nat Commun"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219310232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219310232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:12:20Z","timestamp":1777403540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369219310232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0012369219310232"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2019.04.101","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Group 2 Innate Lymphoid Cells in Airway Diseases","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2019.04.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}